After that, several other studies investigated the diagnostic accuracy of ctDNA in NSCLC patients who progressed to prior EGFR-TKIs, showing a very wide range of concordance rate with the tumor tissue analysis18–35. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.